Paul C. Boutros

About Paul C. Boutros

Paul C. Boutros, With an exceptional h-index of 92 and a recent h-index of 73 (since 2020), a distinguished researcher at University of California, Los Angeles, specializes in the field of Computational Cancer Biology, Benchmarking, Bioinformatics, Prostate Cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Genomic evolution shapes prostate cancer disease type

Association of exercise with pan-cancer incidence and overall survival

PipeVal: light-weight extensible tool for file validation

PD42-05 CORRELATING PROSTATE-SPECIFIC MEMBRANE ANTIGEN WITH MOLECULAR PATHWAYS IN TREATMENT NAÏVE PROSTATE CANCER

Comprehensive Prostate Fluid-Based Spectral Libraries for Enhanced Protein Detection in Urine

Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

NFTest: Automated testing of nextflow pipelines

HPV‐negative head and neck cancers with adverse pathological features carry specific molecular changes that are associated with survival

Paul C. Boutros Information

University

Position

___

Citations(all)

42645

Citations(since 2020)

29904

Cited By

21998

hIndex(all)

92

hIndex(since 2020)

73

i10Index(all)

288

i10Index(since 2020)

252

Email

University Profile Page

Google Scholar

Paul C. Boutros Skills & Research Interests

Computational Cancer Biology

Benchmarking

Bioinformatics

Prostate Cancer

Top articles of Paul C. Boutros

Association of exercise with pan-cancer incidence and overall survival

Cancer Cell

2024/2/12

PipeVal: light-weight extensible tool for file validation

Bioinformatics

2024/2/10

PD42-05 CORRELATING PROSTATE-SPECIFIC MEMBRANE ANTIGEN WITH MOLECULAR PATHWAYS IN TREATMENT NAÏVE PROSTATE CANCER

The Journal of Urology

2024/5

Comprehensive Prostate Fluid-Based Spectral Libraries for Enhanced Protein Detection in Urine

Journal of Proteome Research

2024/4/5

NFTest: Automated testing of nextflow pipelines

Bioinformatics

2024/2/1

HPV‐negative head and neck cancers with adverse pathological features carry specific molecular changes that are associated with survival

Head & Neck

2024/2

Impact of PSMA PET on Prostate Cancer Management

2024/1/25

Mitochondrial dna prostate cancer marker and related systems and methods

2024/1/18

Persistence and dynamics of mutation, selection, and epistasis during the somatic evolution of low-risk, high-risk, and metastatic prostate cancer

Cancer Research

2024/3/22

moPepGen: Rapid and Comprehensive Proteoform Identification

bioRxiv

2024

Understanding and overcoming innate and acquired resistance to type I and II RAF inhibitors in anaplastic thyroid cancer using translational functional genomics

Cancer Research

2024/3/22

Quantifying the seed sensitivity of cancer subclonal reconstruction algorithms

bioRxiv

2024

MOLECULAR CORRELATES WITH PSMA EXPRESSION IN PRIMARY PROSTATE CANCER

Urologic Oncology: Seminars and Original Investigations

2024/3/1

Increased Frequency of Clonal Hematopoiesis of Indeterminate Potential in Bloom Syndrome Probands and Carriers

medRxiv

2024

Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy

Prostate Cancer and Prostatic Diseases

2024/3

Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment

Nature cell biology

2023/12

See List of Professors in Paul C. Boutros University(University of California, Los Angeles)

Co-Authors

academic-engine